Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study Letter

International Collaboration

author list

  • Van Voorhees, A. S.; Stein Gold, L.; Lebwohl, M.; Strober, B.; Sofen, H.; Papp, K.; Bagel, J.; Zhang, Z.; Paris, M.; Wang, Y.

publication date

  • July 14, 2021


published in